Enzymotec (ENZY) in Focus: Stock Moves 8.1% Higher – Tale of the Tape

Zacks

Enzymotec Ltd. (ENZY) was a big mover last session with its shares rising just over 8% on the day. This led to far more shares changing hands on the day than in a normal session. The move breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $6.93 to $7.60.

This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Thursday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Enzymotec currently has a Zacks Rank #4 (Sell) and its Earnings ESP is 0.00%.

A stock worth considering in the Med-Products space is LeMaitre Vascular, Inc. (LMAT) with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply